Hormone Health Hub: Expert Insights on Testing, Balance & Better Living — proactive health

Title: Understanding CardioMetabolic Risk – A Silent Threat We Can’t Ignore The rise in cardiovascular disease (CVD), obesity, and type 2 diabetes (DM2) is one of the most pressing health concerns of our time. CVD remains the leading cause of death for both men and women in the United States. Alarmingly, obesity and insulin resistance—precursors to DM2—significantly increase the risk of developing CVD. Yet, these conditions are largely preventable with early detection and lifestyle changes. So, how can we spot the danger before it's too late? What is CardioMetabolic Risk? Cardiometabolic risk refers to a cluster of modifiable risk factors...

Single nucleotide variations (SNVs) in the enzymes that metabolise estrogen can significantly alter breast cancer risk — in some cases by as much as 12-fold when multiple variants combine. In this detailed scientific overview, Jillian Harrington PhD of ZRT Laboratory explains how variations in CYP11A1, CYP19A1 (aromatase), CYP1B1, COMT and MnSOD affect the estrogen metabolism pathway, why catechol estrogens are dangerous, and how methylation testing can reveal individual vulnerability.

As the days shorten and sunlight fades, four key hormonal systems come under pressure: vitamin D, serotonin, cortisol and melatonin. For those susceptible to Seasonal Affective Disorder (SAD), the disruption of these interconnected rhythms can trigger depression, fatigue, poor sleep and low mood. This article explains the science behind the SAD hormone pattern — and what you can do to support your body through the darker months.